ATIR101 Administered After T-Cell-Depleted Haploidentical HSCT Reduces NRM and Improves Overall Survival in Acute Leukemia
Leukemia - United Kingdom
doi 10.1038/s41375-020-0733-0
Full Text
Open PDFAbstract
Available in full text
Date
February 11, 2020
Authors
Publisher
Springer Science and Business Media LLC